Logo image of ETX

EATON VANCE MUNI INC 2028 TM (ETX) Stock Price, Quote, News and Overview

NYSE:ETX - New York Stock Exchange, Inc. - US27829U1051 - Currency: USD

18.3121  +0.04 (+0.23%)

Fundamental Rating

2

ETX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. ETX has a bad profitability rating. Also its financial health evaluation is rather negative. ETX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ETX had positive earnings in the past year.
ETX had a positive operating cash flow in the past year.
In multiple years ETX reported negative net income over the last 5 years.
ETX had a positive operating cash flow in each of the past 5 years.
ETX Yearly Net Income VS EBIT VS OCF VS FCFETX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

Industry RankSector Rank
ROA -0.17%
ROE -0.23%
ROIC 2%
ROA(3y)-0.49%
ROA(5y)1.61%
ROE(3y)-0.99%
ROE(5y)2.34%
ROIC(3y)2.17%
ROIC(5y)2.07%
ETX Yearly ROA, ROE, ROICETX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

In the last couple of years the Profit Margin of ETX has declined.
ETX's Operating Margin has been stable in the last couple of years.
In the last couple of years the Gross Margin of ETX has remained more or less at the same level.
Industry RankSector Rank
OM 56.59%
PM (TTM) N/A
GM 57.8%
OM growth 3Y-4.76%
OM growth 5Y-0.38%
PM growth 3Y-16.02%
PM growth 5Y-8.14%
GM growth 3Y-4.48%
GM growth 5Y-0.22%
ETX Yearly Profit, Operating, Gross MarginsETX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

2

2. Health

2.1 Basic Checks

ETX has about the same amout of shares outstanding than it did 1 year ago.
ETX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ETX has an improved debt to assets ratio.
ETX Yearly Shares OutstandingETX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ETX Yearly Total Debt VS Total AssetsETX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

ETX has an Altman-Z score of 1.77. This is a bad value and indicates that ETX is not financially healthy and even has some risk of bankruptcy.
The Debt to FCF ratio of ETX is 1.34, which is an excellent value as it means it would take ETX, only 1.34 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.34 indicates that ETX is not too dependend on debt financing.
Even though the debt/equity ratio score it not favorable for ETX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.34
Altman-Z 1.77
ROIC/WACCN/A
WACCN/A
ETX Yearly LT Debt VS Equity VS FCFETX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.32 indicates that ETX may have some problems paying its short term obligations.
A Quick Ratio of 0.32 indicates that ETX may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.32
Quick Ratio 0.32
ETX Yearly Current Assets VS Current LiabilitesETX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 160.47% over the past year.
ETX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.36% yearly.
The Revenue has decreased by -8.90% in the past year.
The Revenue has been decreasing by -3.31% on average over the past years.
EPS 1Y (TTM)160.47%
EPS 3Y-20.62%
EPS 5Y-11.36%
EPS Q2Q%1011.3%
Revenue 1Y (TTM)-8.9%
Revenue growth 3Y-5.31%
Revenue growth 5Y-3.31%
Sales Q2Q%-15.17%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ETX Yearly Revenue VS EstimatesETX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ETX Yearly EPS VS EstimatesETX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 38.96, the valuation of ETX can be described as expensive.
ETX's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 29.63.
Industry RankSector Rank
PE 38.96
Fwd PE N/A
ETX Price Earnings VS Forward Price EarningsETX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 3.82
EV/EBITDA N/A
ETX Per share dataETX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.12%, ETX is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.27, ETX pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.12%

5.2 History

The dividend of ETX decreases each year by -2.88%.
ETX has been paying a dividend for at least 10 years, so it has a reliable track record.
ETX has decreased its dividend recently.
Dividend Growth(5Y)-2.88%
Div Incr Years1
Div Non Decr Years1
ETX Yearly Dividends per shareETX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

ETX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
ETX's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-1693.75%
EPS Next 2YN/A
EPS Next 3YN/A
ETX Yearly Income VS Free CF VS DividendETX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

EATON VANCE MUNI INC 2028 TM

NYSE:ETX (2/21/2025, 8:16:16 PM)

18.3121

+0.04 (+0.23%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners21.84%
Inst Owner Change10.35%
Ins Owners0.04%
Ins Owner Change0%
Market Cap199.42M
Analysts0
Price TargetN/A
Short Float %0.25%
Short Ratio0.95
Dividend
Industry RankSector Rank
Dividend Yield 5.12%
Yearly Dividend0.74
Dividend Growth(5Y)-2.88%
DP-1693.75%
Div Incr Years1
Div Non Decr Years1
Ex-Date02-14 2025-02-14 (0.0782)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 38.96
Fwd PE N/A
P/S 16.21
P/FCF 3.82
P/OCF 3.82
P/B 0.97
P/tB 0.97
EV/EBITDA N/A
EPS(TTM)0.47
EY2.57%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)4.79
FCFY26.17%
OCF(TTM)4.79
OCFY26.17%
SpS1.13
BVpS18.87
TBVpS18.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.17%
ROE -0.23%
ROCE 2.53%
ROIC 2%
ROICexc 2%
ROICexgc 2%
OM 56.59%
PM (TTM) N/A
GM 57.8%
FCFM 424.31%
ROA(3y)-0.49%
ROA(5y)1.61%
ROE(3y)-0.99%
ROE(5y)2.34%
ROIC(3y)2.17%
ROIC(5y)2.07%
ROICexc(3y)2.21%
ROICexc(5y)2.09%
ROICexgc(3y)2.21%
ROICexgc(5y)2.09%
ROCE(3y)2.74%
ROCE(5y)2.61%
ROICexcg growth 3Y4.97%
ROICexcg growth 5Y4.62%
ROICexc growth 3Y4.97%
ROICexc growth 5Y4.61%
OM growth 3Y-4.76%
OM growth 5Y-0.38%
PM growth 3Y-16.02%
PM growth 5Y-8.14%
GM growth 3Y-4.48%
GM growth 5Y-0.22%
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.34
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 2.43
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.32
Quick Ratio 0.32
Altman-Z 1.77
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)160.47%
EPS 3Y-20.62%
EPS 5Y-11.36%
EPS Q2Q%1011.3%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.9%
Revenue growth 3Y-5.31%
Revenue growth 5Y-3.31%
Sales Q2Q%-15.17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-22.06%
EBIT growth 3Y-9.82%
EBIT growth 5Y-3.67%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y401.35%
FCF growth 3Y103.55%
FCF growth 5Y49.12%
OCF growth 1Y401.35%
OCF growth 3Y103.55%
OCF growth 5Y49.12%